1999 Abstract: 4674 SUPPRESSION OF GASTRIC ACID SECRETION IN PATIENTS WITH GERD RESULTS IN BACTERIAL OVERGROWTH AND DECONJUGATION OF BILE SALTS
Abstracts
|
||||||||||||||||||||||||||||||||||
Objective: The effect of chronic acid suppression therapy on gastric bacterial overgrowth and its potential impact on bile salt deconjugation in patients with gastro-esophageal-reflux disease (GERD) is unknown. These drug-induced changes may contribute significantly to the composition of the refluxate. Our aim was to study the effect of bacterial overgrowth on bile salt composition and deconjugation in patients on acid suppression therapy. Methods: Thirty consecutive patients with GERD and abnormal 24h-esophageal pH exposure were treated with 20-40 mg omeprazole for at least 3 months. Ten patients with GERD not taking omeprazole for at least 2 weeks represent the control group. At time of endoscopy 5 to 10 ml of gastric juice were aspirated and the pH was determined with a glass probe after precalibration and plated for bacterial growth. Type and conjugation status of bile salts was assessed and quantified with HPLC. A bacterial count > 103/ml was considered abnormal overgrowth. Results: Bacterial overgrowth was found in 11/30 patients taking omeprazole and in 1/10 patient in the control group. Bacterial overgrowth only occurred when the pH was >3.8. The ratio of conjugated:unconjugated bile salts dramatically changed, even reversed in the bacterial positive specimen. Conclusion: Chronic acid suppression therapy results in both bacterial overgrowth and bile salt deconjugation in approximately 30% of the patients. Given that deconjugated bile salts are more toxic their reflux may amplify esophageal mucosal injury. This study demonstrates for the first time deconjugation of bile salts in the foregut secondary to bacterial overgrowth. Copyright 1996 - 1999, SSAT, Inc. |